✦ LIBER ✦

Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer

✍ Scribed by Grande, Carlos; Quintero, Guillermo; Candamio, Sonia; París Bouzas, Lorena; Villanueva, María José; Campos, Begoña; Gallardo, Elena; Alvarez, Elena; Casal, Joaquín; Mel, José Ramón

Book ID: 122661958
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 337 KB
Volume: 4
Category: Article
ISSN: 1879-4068
DOI: 10.1016/j.jgo.2013.01.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

669 PUBLICATION Capecitabine and oxalipl

669 PUBLICATION Capecitabine and oxaliplatin (XELOX) as first-line treatment for elderly patients (pts) with advanced / metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

XELOX (capecitabine plus oxaliplatin) as

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

✍ Feliu, J; Salud, A; Escudero, P; Lopez-Gómez, L; Bolaños, M; Galán, A; Vicent, J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Capecitabine and bevacizumab as first-li

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

✍ Feliu, J; Safont, M J; Salud, A; Losa, F; García-Girón, C; Bosch, C; Escudero, P 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 286 KB

Phase II study of capecitabine plus oxal

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF

Bevacizumab in combination with biweekly

Bevacizumab in combination with biweekly capecitabine and irinotecan, as first-line treatment for patients with metastatic colorectal cancer

✍ García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Rie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB